These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 26296371)

  • 1. The correlation between the electrode configuration and histopathology of irreversible electroporation ablations in prostate cancer patients.
    van den Bos W; de Bruin DM; Jurhill RR; Savci-Heijink CD; Muller BG; Varkarakis IM; Skolarikos A; Zondervan PJ; Laguna-Pes MP; Wijkstra H; de Reijke TM; de la Rosette JJ
    World J Urol; 2016 May; 34(5):657-64. PubMed ID: 26296371
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The safety and efficacy of irreversible electroporation for the ablation of prostate cancer: a multicentre prospective human in vivo pilot study protocol.
    van den Bos W; de Bruin DM; Muller BG; Varkarakis IM; Karagiannis AA; Zondervan PJ; Laguna Pes MP; Veelo DP; Savci Heijink CD; Engelbrecht MRW; Wijkstra H; de Reijke TM; de la Rosette JJMCH
    BMJ Open; 2014 Oct; 4(10):e006382. PubMed ID: 25354827
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Histopathological Outcomes after Irreversible Electroporation for Prostate Cancer: Results of an Ablate and Resect Study.
    van den Bos W; Jurhill RR; de Bruin DM; Savci-Heijink CD; Postema AW; Wagstaff PG; Muller BG; Varkarakis IM; Skolarikos A; Zondervan PJ; Laguna Pes MP; de Reijke TM; de la Rosette JJ
    J Urol; 2016 Aug; 196(2):552-9. PubMed ID: 27004693
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MRI and contrast-enhanced ultrasound imaging for evaluation of focal irreversible electroporation treatment: results from a phase I-II study in patients undergoing IRE followed by radical prostatectomy.
    van den Bos W; de Bruin DM; van Randen A; Engelbrecht MR; Postema AW; Muller BG; Varkarakis IM; Skolarikos A; Savci-Heijink CD; Jurhill RR; Zondervan PJ; Laguna Pes MP; Wijkstra H; de Reijke TM; de la Rosette JJ
    Eur Radiol; 2016 Jul; 26(7):2252-60. PubMed ID: 26449559
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oncological and Quality-of-life Outcomes Following Focal Irreversible Electroporation as Primary Treatment for Localised Prostate Cancer: A Biopsy-monitored Prospective Cohort.
    Blazevski A; Scheltema MJ; Yuen B; Masand N; Nguyen TV; Delprado W; Shnier R; Haynes AM; Cusick T; Thompson J; Stricker P
    Eur Urol Oncol; 2020 Jun; 3(3):283-290. PubMed ID: 31103721
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Production of Spherical Ablations Using Nonthermal Irreversible Electroporation: A Laboratory Investigation Using a Single Electrode and Grounding Pad.
    Sano MB; Fan RE; Hwang GL; Sonn GA; Xing L
    J Vasc Interv Radiol; 2016 Sep; 27(9):1432-1440.e3. PubMed ID: 27478129
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of Focal vs Extended Irreversible Electroporation for the Ablation of Localized Low- or Intermediate-Risk Prostate Cancer on Early Oncological Control: A Randomized Clinical Trial.
    Zhang K; Teoh J; Laguna P; Dominguez-Escrig J; Barret E; Ramon-Borja JC; Muir G; Bohr J; de Reijke TM; Pelechano Gómez P; Ng CF; Sanchez-Salas R; de la Rosette J
    JAMA Surg; 2023 Apr; 158(4):343-349. PubMed ID: 36723911
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel platinum bipolar electrode for irreversible electroporation in prostate cancer: preclinical study in the beagle prostate.
    Lim B; Kim HB; Jeong S; Kim SH; Kang JM; Park Y; Won DS; Kim JW; Ryu DS; Kim Y; Park JH; Kim CS
    Sci Rep; 2021 Aug; 11(1):17194. PubMed ID: 34433890
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Focal vs extended ablation in localized prostate cancer with irreversible electroporation; a multi-center randomized controlled trial.
    Scheltema MJ; van den Bos W; de Bruin DM; Wijkstra H; Laguna MP; de Reijke TM; de la Rosette JJ
    BMC Cancer; 2016 May; 16():299. PubMed ID: 27150293
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Percutaneous irreversible electroporation (IRE) of prostate cancer: Contrast-enhanced ultrasound (CEUS) findings during follow up.
    Beyer LP; Pregler B; Nießen C; Michalik K; Haimerl M; Stroszczynski C; Jung EM; Wiggermann P
    Clin Hemorheol Microcirc; 2016; 64(3):501-506. PubMed ID: 27935553
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Irreversible electroporation ablation: creation of large-volume ablation zones in in vivo porcine liver with four-electrode arrays.
    Appelbaum L; Ben-David E; Faroja M; Nissenbaum Y; Sosna J; Goldberg SN
    Radiology; 2014 Feb; 270(2):416-24. PubMed ID: 24126371
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Initial Assessment of the Efficacy of Irreversible Electroporation in the Focal Treatment of Localized Renal Cell Carcinoma With Delayed-interval Kidney Tumor Resection (Irreversible Electroporation of Kidney Tumors Before Partial Nephrectomy [IRENE] Trial-An Ablate-and-Resect Pilot Study).
    Wendler JJ; Pech M; Fischbach F; Jürgens J; Friebe B; Baumunk D; Porsch M; Blaschke S; Schindele D; Siedentopf S; Ricke J; Schostak M; Köllermann J; Liehr UB
    Urology; 2018 Apr; 114():224-232. PubMed ID: 29305201
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Focal ablation of apical prostate cancer lesions with irreversible electroporation (IRE).
    Blazevski A; Amin A; Scheltema MJ; Balakrishnan A; Haynes AM; Barreto D; Cusick T; Thompson J; Stricker PD
    World J Urol; 2021 Apr; 39(4):1107-1114. PubMed ID: 32488359
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Irreversible electroporation (IRE): a narrative review of the development of IRE from the laboratory to a prostate cancer treatment.
    Blazevski A; Scheltema MJ; Amin A; Thompson JE; Lawrentschuk N; Stricker PD
    BJU Int; 2020 Mar; 125(3):369-378. PubMed ID: 31725935
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Irreversible electroporation for the treatment of localized prostate cancer: a summary of imaging findings and treatment feedback.
    Scheltema MJ; Postema AW; de Bruin DM; Buijs M; Engelbrecht MR; Laguna MP; Wijkstra H; de Reijke TM; de la Rosette JJMCH
    Diagn Interv Radiol; 2017; 23(5):365-370. PubMed ID: 28830850
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ablation outcome of irreversible electroporation on potato monitored by impedance spectrum under multi-electrode system.
    Zhao Y; Liu H; Bhonsle SP; Wang Y; Davalos RV; Yao C
    Biomed Eng Online; 2018 Sep; 17(1):126. PubMed ID: 30236121
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Numerical simulation modeling of the irreversible electroporation treatment zone for focal therapy of prostate cancer, correlation with whole-mount pathology and T2-weighted MRI sequences.
    Scheltema MJ; O'Brien TJ; van den Bos W; de Bruin DM; Davalos RV; van den Geld CWM; Laguna MP; Neal RE; Varkarakis IM; Skolarikos A; Stricker PD; de Reijke TM; Arena CB; de la Rosette J
    Ther Adv Urol; 2019; 11():1756287219852305. PubMed ID: 31217820
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The optimization of needle electrode number and placement for irreversible electroporation of hepatocellular carcinoma.
    Adeyanju OO; Al-Angari HM; Sahakian AV
    Radiol Oncol; 2012 Jun; 46(2):126-35. PubMed ID: 23077449
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of Hepatic Lesions After non-Thermal Tumor Ablation by Irreversible Electroporation in a Pig Model.
    Jeon SM; Davaa E; Jiang Y; Jenjob R; Truong NT; Shin KJ; Jeong S; Yang SG
    Technol Cancer Res Treat; 2023; 22():15330338221147122. PubMed ID: 37861099
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of an endorectal electrode for performing focused irreversible electroporation ablations in the Swine rectum.
    Srimathveeravalli G; Wimmer T; Monette S; Gutta NB; Ezell PC; Maybody M; Weiser MR; Solomon SB
    J Vasc Interv Radiol; 2013 Aug; 24(8):1249-56. PubMed ID: 23796856
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.